- Report
- June 2024
Canada, Mexico, North America Canada, Mexico, North America
From €9192EUR$9,700USD£7,757GBP
- Report
- June 2024
France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From €16583EUR$17,500USD£13,995GBP
- Report
- October 2020
- 1980 Pages
Latin America, Asia Pacific, ... Latin America, Asia Pacific, Global, Europe, North America, Africa, Middle East
From €45958EUR$48,500USD£38,787GBP
- Report
- October 2024
- 280 Pages
Global
From €2516EUR$2,655USD£2,123GBP
The Human Leukocyte Antigen (HLA) Test is a type of In Vitro Diagnostics (IVD) used to identify the presence of certain antigens in a patient's blood. It is used to diagnose a variety of conditions, including autoimmune diseases, organ transplantation, and blood transfusions. The test is also used to determine the compatibility of donor organs for transplantation. The HLA Test market is a rapidly growing segment of the IVD market, driven by the increasing prevalence of autoimmune diseases and the need for organ transplants. The market is expected to benefit from the development of new technologies and the introduction of new products.
Some of the major companies in the HLA Test market include Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN, Illumina, and Agilent Technologies. Show Less Read more